We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALDX icon
2601
Aldeyra Therapeutics
ALDX
$94.7M
$959 ﹤0.01%
185
SOUN icon
2602
SoundHound AI
SOUN
$2.83B
$958 ﹤0.01%
+96
New +$1.38K
WLY icon
2603
John Wiley & Sons Class A
WLY
$2.57B
$950 ﹤0.01%
31
-13
-30% -$458
WOOD icon
2604
iShares Global Timber & Forestry ETF
WOOD
$261M
$937 ﹤0.01%
13
MLR icon
2605
Miller Industries
MLR
$589M
$935 ﹤0.01%
25
-15
-38% -$584
ACLX
2606
DELISTED
Arcellx
ACLX
$913 ﹤0.01%
14
LWLG icon
2607
Lightwave Logic
LWLG
$949M
$898 ﹤0.01%
+277
New +$1.23K
SBCF icon
2608
Seacoast Banking Corp of Florida
SBCF
$3.27B
$880 ﹤0.01%
28
APEI icon
2609
American Public Education
APEI
$885M
$870 ﹤0.01%
23
NVEC icon
2610
NVE Corp
NVEC
$578M
$831 ﹤0.01%
14
-40
-74% -$2.67K
LNN icon
2611
Lindsay Corp
LNN
$1.16B
$826 ﹤0.01%
7
-313
-98% -$37.7K
BTG icon
2612
B2Gold
BTG
$5.2B
$817 ﹤0.01%
181
+148
+448% +$690
GERN icon
2613
Geron
GERN
$956M
$814 ﹤0.01%
616
-40
-6% -$50
MITK icon
2614
Mitek Systems
MITK
$789M
$813 ﹤0.01%
77
RXO icon
2615
RXO
RXO
$4.25B
$809 ﹤0.01%
64
-1,226
-95% -$18.1K
MLAB icon
2616
Mesa Laboratories
MLAB
$537M
$785 ﹤0.01%
+10
New +$761
WAFD icon
2617
WaFd
WAFD
$2.73B
$769 ﹤0.01%
24
NRGV icon
2618
Energy Vault
NRGV
$535M
$752 ﹤0.01%
163
-197
-55% -$753
ASMB icon
2619
Assembly Biosciences
ASMB
$511M
$749 ﹤0.01%
22
ACAD icon
2620
Acadia Pharmaceuticals
ACAD
$4.34B
$748 ﹤0.01%
28
-28
-50% -$669
NLOP
2621
Net Lease Office Properties
NLOP
$169M
$748 ﹤0.01%
29
-94
-76% -$2.66K
TALK icon
2622
Talkspace
TALK
$873M
$734 ﹤0.01%
202
CLMB icon
2623
Climb Global Solutions
CLMB
$484M
$720 ﹤0.01%
28
FDMT icon
2624
4D Molecular Therapeutics
FDMT
$536M
$713 ﹤0.01%
95
AMPL icon
2625
Amplitude
AMPL
$1.11B
$707 ﹤0.01%
61

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.